Sibrotuzumab is a humanized IgG1 monoclonal antibody that targets fibroblast activation protein (FAP). IL-12 is a cytokine that is naturally produced by cells such as dendritic cells, macrophages, neutrophils, helper T cells, and human B lymphoblasts. It plays a crucial role in immune responses, especially in T cell-mediated inflammatory responses. The product is a human recombinant anti-human FAP-IL12 fusion protein. This is a novel FAP-specific immunocytokine, which is generated by fusing murine IL-12 to the N-terminus of Sibrotuzumab in a tandem diabody format.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-211 | Anti-Human FAP Recombinant Antibody (TAB-211) | ELISA, IP, FC, FuncS, Neut, IF, WB | IgG1 - kappa |
There are currently no Customer reviews or questions for VS-0624-FY92. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.